Drugmakers Least Exposed in Deficit Deal

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

Oct. 23 (Bloomberg) –- Matt Barry, a health-care analyst with Bloomberg Government, discusses how a deficit reduction deal involving Medicare and Medicaid may affect the five largest publicly traded home health providers and nursing homes more than drugmakers. Barry outlines the findings in a Bloomberg Government Study, “Home Health Providers At Risk in Deficit Deal, Not So Drugmakers.” (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change